Results for tag: "Diabetic Eye Disease Drug"

The Diabetic Eye Disease Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat diabetic retinopathy, a condition caused by diabetes that can lead to vision loss. The drugs are typically administered as intravitreal injections, which are injections directly into the eye. They are used to reduce the risk of vision loss and improve vision in patients with diabetic retinopathy. The Diabetic Eye Disease Drug market is highly competitive, with a number of companies offering products. Some of the major players in the market include Regeneron Pharmaceuticals, Novartis, Allergan, and Roche. Other companies in the market include Bayer, Santen Pharmaceuticals, and Ophthotech. Show Less Read more